v3.26.1
SCHEDULE OF BASIC AND DILUTED EARNINGS PER SHARE (Details) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Earnings Per Share [Abstract]    
Net loss from continuing operations $ (8,872,596) $ (1,645,355)
Less: Preferred stock dividends (776,563) (776,563)
Net loss from continuing operations attributable to LifeMD, Inc. common stockholders (9,649,159) (2,421,918)
Net income from discontinued operations 1,993,422
Less: Net income attributable to noncontrolling interests of discontinued operations 531,845
Net income from discontinued operations attributable to LifeMD, Inc. 1,461,577
Net loss attributable to LifeMD, Inc. common stockholders $ (9,649,159) $ (960,341)